{
    "organizations": [],
    "uuid": "fcc173084ff553ac1bb6224731a5d84e3a626708",
    "author": "",
    "url": "https://www.reuters.com/article/brief-sorrento-therapeutics-unit-receive/brief-sorrento-therapeutics-unit-receives-fda-approval-for-non-opioid-ztlido-idUSASB0C81Z",
    "ord_in_thread": 0,
    "title": "BRIEF-Sorrento Therapeutics' Unit Receives FDA Approval For Non-Opioid Ztlido",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "February 28, 2018 / 7:17 PM / Updated 22 minutes ago BRIEF-Sorrento Therapeutics' Unit Receives FDA Approval For Non-Opioid Ztlido Reuters Staff 1 Min Read Feb 28 (Reuters) - Sorrento Therapeutics Inc: * SORRENTO THERAPEUTICS SUBSIDIARY, SCILEX, RECEIVES US FDA APPROVAL FOR NON-OPIOID ZTLIDO™ (LIDOCAINE TOPICAL SYSTEM) 1.8% FOR PHN PAIN * SORRENTO THERAPEUTICS SUBSIDIARY, SCILEX, RECEIVES US FDA APPROVAL FOR NON-OPIOID ZTLIDO™ (LIDOCAINE TOPICAL SYSTEM) 1.8% FOR PHN PAIN * SORRENTO THERAPEUTICS INC - ‍INTEND TO EXPLORE EXPANSION OF ZTLIDO INTO ADDITIONAL INDICATIONS​ * SORRENTO THERAPEUTICS INC - ‍OBJECTIVE TO MAKE PRODUCT COMMERCIALLY AVAILABLE TO PATIENTS SOMETIME IN 2018​ * SORRENTO THERAPEUTICS - INTENDS TO HAVE SCILEX COMPLETE FINAL STEPS NECESSARY TO COMMERCIAL LAUNCH OF ZTLIDO IN U.S. Source text for Eikon: Further company coverage:",
    "published": "2018-02-28T21:17:00.000+02:00",
    "crawled": "2018-02-28T21:34:50.083+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "february",
        "pm",
        "updated",
        "minute",
        "ago",
        "therapeutic",
        "unit",
        "receives",
        "fda",
        "approval",
        "ztlido",
        "reuters",
        "staff",
        "min",
        "read",
        "feb",
        "reuters",
        "sorrento",
        "therapeutic",
        "inc",
        "sorrento",
        "therapeutic",
        "subsidiary",
        "scilex",
        "receives",
        "u",
        "fda",
        "approval",
        "lidocaine",
        "topical",
        "system",
        "phn",
        "pain",
        "sorrento",
        "therapeutic",
        "subsidiary",
        "scilex",
        "receives",
        "u",
        "fda",
        "approval",
        "lidocaine",
        "topical",
        "system",
        "phn",
        "pain",
        "sorrento",
        "therapeutic",
        "inc",
        "explore",
        "expansion",
        "ztlido",
        "additional",
        "sorrento",
        "therapeutic",
        "inc",
        "make",
        "product",
        "commercially",
        "available",
        "patient",
        "sometime",
        "sorrento",
        "therapeutic",
        "intends",
        "scilex",
        "complete",
        "final",
        "step",
        "necessary",
        "commercial",
        "launch",
        "ztlido",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}